The term Ruvbl2 Activators would refer to a class of chemical compounds designed to specifically interact with and enhance the activity of Ruvbl2, a protein that is part of the AAA+ (ATPases Associated with diverse cellular Activities) family. Ruvbl2, also known as RuvB-like 2, plays a role in complex cellular processes involving DNA repair, transcription, and chromatin remodeling. It functions as part of multi-protein complexes, and its activity is dependent on its ATPase activity, which provides the energy necessary for its role in these molecular processes. Activators of Ruvbl2 would, therefore, be molecules that bind to the protein in a manner that increases its ATPase activity, either by stabilizing the active form of the protein, by facilitating ATP binding or hydrolysis, or by promoting the protein's interaction with other components of the cellular machinery. The discovery and refinement of such activators would involve detailed structure-activity relationship studies, leveraging techniques such as high-throughput screening to identify candidate molecules, and subsequent optimization to enhance their potency and selectivity.
From an experimental perspective, the journey to characterize Ruvbl2 activators begins with in vitro assays to monitor the ATPase activity of Ruvbl2 in the presence of these compounds. These assays could employ methods such as colorimetric phosphate release measurements or coupling ATP hydrolysis to a detectable reporter system. Once potential activators are identified, further analysis would be required to understand their mechanism of action. This could involve kinetic studies to determine how the compounds affect Ruvbl2 activity, including assessments of changes in the enzyme's Km (affinity for ATP) and Vmax (maximum rate of reaction). Biophysical methods like surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) would be invaluable for investigating the interaction between Ruvbl2 and its activators, providing insights into binding affinities and the thermodynamics of the interaction. Structural studies using techniques such as X-ray crystallography or cryo-electron microscopy could reveal the activators' binding sites and the conformational changes induced in Ruvbl2 upon binding. Such detailed molecular characterization would be essential for understanding how these compounds enhance Ruvbl2's ATPase activity and, in turn, how they might affect the various biological processes in which Ruvbl2 is involved.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could unsilence genes by reducing methylation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it can promote a more relaxed chromatin state and potentially enhance gene transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
It acts as a transcriptional regulator by activating retinoic acid receptors, which can influence gene expression patterns. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
It activates protein kinase C, influencing multiple signaling pathways and potentially gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
It is a histone deacetylase inhibitor that can impact gene expression by altering chromatin structure. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
This drug binds to DNA and affects the transcription of various genes. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
It intercalates DNA, inhibiting transcription elongation by RNA polymerase. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, it affects cell growth and proliferation, potentially influencing gene expression profiles. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which may alter transcription factor activity and gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAP kinase inhibitor can affect signaling pathways that regulate gene expression. | ||||||